PHP
FMTX

Parkman Healthcare Partners’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Parkman Healthcare Partners’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-78,603
Closed -$542K – 100
2022
Q2 		$542K Sell
78,603
-45,707
-37% -$321K 0.2% 68
2022
Q1 		$1.16M Buy
124,310
+24,310
+24% +$259K 0.34% 65
2021
Q4 		$1.42M Buy
+100,000
New +$1.73M 0.31% 67

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

Parkman Healthcare Partners's FMTX Position: Q3 2022 in Review

Parkman Healthcare Partners sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 78,603 shares — an estimated $542K sold.

Parkman Healthcare Partners first reported a position in FMTX in Q4 2021 and held it in 3 quarters. The position peaked at $1.42M in Q4 2021. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

  • Parkman Healthcare Partners reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 78,603 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $542K.
  • Parkman Healthcare Partners first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Parkman Healthcare Partners's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.42M in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Parkman Healthcare Partners's 13F filing for Q3 2022, filed 14 Nov 2022.